Safety of antibody-drug conjugates in gynecologic cancers: current evidence and management approaches

Francisco Javier Calleja-Holgado & Ainhoa Madariaga et al. · 2025-08-19

2Citations
TL;DR

A comprehensive overview of the evolving ADC pipeline in gynecologic cancers is provided, with a particular focus on toxicity patterns, underlying mechanisms, and evidence-based management strategies to support safe and effective integration into routine oncology practice.

AI-generated by Semantic Scholar